In anemia of chronic disease (ACD), the mean corpuscular volume (MCV) is usually normal, somewhere in the 80 to 100 femtoliter range. It becomes mildly low in some patients, typically in the 70s and rarely below that. An MCV alone cannot confirm ACD, though. You need to look beyond it at ferritin, transferrin saturation, and inflammatory markers to separate ACD from iron deficiency, which it closely resembles.
This article explains why the MCV behaves the way it does in ACD, which other tests actually make the diagnosis, and how the condition is managed.
What Is Anemia of Chronic Disease?
Anemia of chronic disease, also called anemia of inflammation, develops in people with long-lasting inflammatory conditions. Common examples are rheumatoid arthritis, lupus, inflammatory bowel disease, chronic infections such as tuberculosis, and many cancers. It is one of the most common anemias in hematology practice, especially among older adults and hospital patients.
Unlike iron deficiency, ACD is not caused by missing iron. The body usually has enough iron, sometimes plenty, but inflammation stops it from reaching the bone marrow. Inflammation also dampens red blood cell production and slightly shortens red cell survival. The result is usually a mild to moderate anemia, with hemoglobin often between 8 and 11 g/dL.
Why the MCV Is Normal or Slightly Low
The Hepcidin Mechanism
The key player is hepcidin, a hormone made by the liver. Inflammatory signals, especially interleukin-6 (IL-6), push hepcidin levels up. Hepcidin blocks ferroportin, the channel iron uses to leave gut cells and the macrophages that recycle old red cells. As a result, iron is trapped in storage and absorption from food falls.
Other inflammatory messengers, such as interleukin-1 and tumor necrosis factor, make marrow precursors less responsive to erythropoietin, the kidney hormone that drives red cell production. They can also blunt the amount of erythropoietin released.
From Iron Restriction to Cell Size
Early on, the marrow still gets enough iron to make normal-sized cells, only fewer of them, so the MCV stays normal. If the iron restriction is severe and lasts a long time, hemoglobin synthesis slows enough for cells to become smaller, and the MCV drifts down. That is why a mildly low MCV fits ACD, but an MCV well below the low 70s should make you think of iron deficiency or thalassemia trait instead.
Beyond MCV: The Tests That Make the Diagnosis
A complete blood count confirms anemia and gives the MCV and red cell distribution width (RDW). The next step is iron studies interpreted together with a measure of inflammation such as C-reactive protein (CRP) or the erythrocyte sedimentation rate (ESR). The reticulocyte count is usually low, which shows that the marrow is underproducing rather than cells being lost or destroyed.
| Test | Anemia of chronic disease | Iron deficiency anemia | Both together |
|---|---|---|---|
| MCV | Normal or mildly low | Low | Low |
| RDW | Usually normal | High | Often high |
| Serum iron | Low | Low | Low |
| TIBC / transferrin | Low or normal | High | Low or normal |
| Transferrin saturation | Low | Low | Low |
| Ferritin | Normal or high | Low (often under 30 ng/mL) | Low to normal |
| Soluble transferrin receptor | Normal | High | High |
| CRP / ESR | Often raised | Usually normal | Often raised |
Reading Ferritin With Care
Ferritin reflects iron stores, but it is also an acute-phase protein that rises with inflammation. A ferritin that looks “normal” in someone with active arthritis may be hiding real iron deficiency. Many hematologists therefore treat a ferritin below about 100 ng/mL, combined with low transferrin saturation in an inflamed patient, as suggesting that true iron deficiency coexists with ACD.
When the Picture Is Mixed
Mixed anemia is common. For example, a person with inflammatory bowel disease may have both inflammation and bleeding from the gut. The soluble transferrin receptor, or its ratio to the log of ferritin, can help because it rises in iron deficiency but not in pure ACD. Chronic kidney disease adds a further layer, because the damaged kidneys make less erythropoietin.
Symptoms and Clinical Picture
Because ACD is usually mild and develops slowly, symptoms are often subtle and overlap with those of the underlying illness:
- Fatigue and reduced exercise tolerance
- Breathlessness on exertion
- Pallor
- Poor concentration
In my practice, patients often put their tiredness down to their arthritis or cancer. Only a blood count shows how much the anemia is adding. Significant symptoms at rest, or a hemoglobin that falls quickly, suggest something beyond ACD alone.
Treatment and Management
Treat the Underlying Disease
The most effective treatment for ACD is controlling the inflammation that drives it. When rheumatoid arthritis, inflammatory bowel disease, or an infection is brought under control, hepcidin falls and hemoglobin often recovers without any specific anemia treatment. This remains the foundation of anemia management in chronic disease.
Iron Therapy
Oral iron works poorly in ACD because high hepcidin blocks absorption from the gut. When iron deficiency coexists, intravenous iron is often the better choice, since it bypasses the gut. Iron should not be given routinely to patients with pure ACD and adequate stores.
Erythropoiesis-Stimulating Agents and Transfusion
Erythropoiesis-stimulating agents (ESAs), such as epoetin alfa, are mainly used in chronic kidney disease and in selected patients receiving chemotherapy. Doctors aim for a modest hemoglobin target rather than a fully normal level, because pushing hemoglobin higher with ESAs raises the risk of blood clots and cardiovascular events. Blood transfusion is kept for severe or symptomatic anemia.
Key Takeaways
- The MCV in anemia of chronic disease is usually normal and sometimes mildly low. A markedly low MCV points elsewhere.
- Hepcidin, driven by inflammation, traps iron in storage and is the central mechanism.
- Diagnosis rests on iron studies read alongside CRP or ESR, with ferritin interpreted in the context of inflammation.
- Treating the underlying disease is the main therapy. Intravenous iron and ESAs have specific, limited roles.
For a wider overview of anemia types, see our anemia guide.
Frequently Asked Questions
What is the typical MCV in anemia of chronic disease?
Most patients have an MCV in the normal range of about 80 to 100 fL. Some develop a mildly low MCV, usually in the 70s. Values much lower than that suggest iron deficiency or thalassemia trait.
Can anemia of chronic disease and iron deficiency occur together?
Yes, and it happens often, especially with bowel inflammation, heavy periods, or use of anti-inflammatory drugs. Ferritin can be misleading in this situation, so doctors may use transferrin saturation, the soluble transferrin receptor, or a trial of intravenous iron to sort it out.
Will iron tablets fix anemia of chronic disease?
Usually not. Hepcidin blocks iron absorption from the gut, and the body already has iron stores it cannot use. Iron is only helpful when true iron deficiency is also present, and then the intravenous route often works better.
Does anemia of chronic disease go away?
It frequently improves when the underlying condition is controlled. If the illness stays active, the anemia tends to persist at a stable, mild level.
